Partial androgen suppression c... [Prostate Cancer Prostatic Dis. 2009] - PubMed

loading

Reversibility of androgen deprivation therapy in patients with prostate cancer. [J Urol. 2005]
Reversibility of androgen deprivation therapy in patients with prostate cancer.
Fridmans A, Chertin B, Koulikov D, Lindenberg T, Gelber H, Leiter C, Farkas A, Spitz IM. J Urol. 2005 Mar; 173(3):784-9.
Hormonal therapy of prostate cancer. [Prog Brain Res. 2010]
Hormonal therapy of prostate cancer.
Labrie F. Prog Brain Res. 2010; 182:321-41.
Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen. [Int J Urol. 2010]
Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen.
Narimoto K, Mizokami A, Izumi K, Mihara S, Sawada K, Sugata T, Shimamura M, Miyazaki K, Nishino A, Namiki M. Int J Urol. 2010 Apr; 17(4):337-45. Epub 2010 Mar 1.
Review Anti-androgens and other hormonal therapies for prostate cancer. [Urology. 1999]
Review Anti-androgens and other hormonal therapies for prostate cancer.
Richie JP. Urology. 1999 Dec; 54(6A Suppl):15-8.
Review Monotherapy in advanced prostate cancer: an overview. [Exp Oncol. 2004]
Review Monotherapy in advanced prostate cancer: an overview.
Baltogiannis D, Giannakopoulos X, Charalabopoulos K, Sofikitis N. Exp Oncol. 2004 Sep; 26(3):185-91.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Partial androgen suppression consequent to increased secretion of adrenal androg...
Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.
Prostate Cancer Prostatic Dis. 2009 ;12(1):100-3. Epub 2008 Jun 24 .

PubMed
Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon...
Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.
Oncogene. 2008 Oct 9 ;27(46):6068-74. Epub 2008 Jun 23 .

PubMed
Cycle and hormone changes during perimenopause: the key role of ovarian function...
Cycle and hormone changes during perimenopause: the key role of ovarian function.
Menopause. 2008 Jul-Aug ;15(4 Pt 1):603-12.

PubMed
The impact of continuous lateral rotation therapy in overall clinical and financ...
The impact of continuous lateral rotation therapy in overall clinical and financial outcomes of critically ill patients.
Crit Care Nurs Q. 2008 Jul-Sep ;31(3):270-9.

PubMed
[Pulmonary hypertension and cor pulmonale caused by chronic obstructive lung dis...
[Pulmonary hypertension and cor pulmonale caused by chronic obstructive lung disease; pathogenesis and treatment].
Ned Tijdschr Geneeskd. 1991 Jun 22 ;135(25):1120-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed